Connect With Viral Vector Manufacturing Leaders
Manufacturing viral vectors for cell and gene therapies remains expensive, time-consuming, and often constrained by low yields, process variability, and increasing regulatory expectations. Without robust, reliable, and reproducible manufacturing processes, therapies risk slower clinical progression, higher costs, and limited patient access, particularly for populations where time is critical.
That's why leading organizations including Ultragenyx, Regeneron, Alexion, Legend Biotech, Sanofi, Neurocrine Biosciences, Affinia Therapeutics, and more are attending the 5th Viral Vector Process Development & Manufacturing Summit to uncover practical solutions for improving transfection consistency, optimizing purification strategies, increasing productivity, reducing CMC burden, and scaling manufacturing with confidence.
To achieve these goals, developers are actively seeking support from CDMOs, reagent providers, analytical and assay specialists, process development technology providers, manufacturing equipment suppliers, and viral vector service partners.
As a key contributor to the future of cell and gene therapy manufacturing, this is your opportunity to help bridge the gap between manufacturing limitations and broader patient access. Join the companies working to make viral vector production more scalable, affordable, and commercially viable, enabling life-changing therapies to reach the patients who need them faster.
What to Expect
Strengthen Your Position as a Trusted Industry Partner
Showcase your expertise in front of viral vector developers actively seeking solutions to improve productivity, scalability, and manufacturing robustness. Build credibility with the teams driving the future of AAV and LVV manufacturing.
Connect with New Viral Vector Clients
Connect with viral vector leaders actively seeking solutions to improve manufacturing productivity and scalability. Demonstrate your value to qualified prospects and generate new commercial opportunities in just two days.
Gain Insight into Latest Viral Vector Manufacturing Priorities
Hear directly how leading developers are tackling transfection variability, purification bottlenecks, process scale-up, and cost-of-goods challenges. Use these insights to refine your solutions, align with evolving customer needs, and identify new commercial opportunities.
Key Services & Solutions
Our attendees are actively seeking service and solution providers with expertise across viral vector process development and manufacturing, including but not limited to:
Contract Development Manufacturing Organization
Reagent Providers
Analytical/Assay Providers
Delivery Platforms
Other Process Development & Manufacturing Solutions
Hear What Our Past Sponsors Have to Say
Extremely curated attendees and content for our technology. The smaller group made it more amenable to meeting everyone at some point. Also loved the speed networking!
Vice President, Sales & Marketing, Cellevate AB
I thought the presentations this year were diverse and covered numerous areas of viral vector development.
Business Development Manager, Teknova
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
Whether your objective is to build brand awareness, generate qualified leads, launch a new solution, or position your company at the center of viral vector manufacturing innovation, we offer a range of opportunities to help you achieve your commercial goals.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Oliver Smare
Business Development Manager